The role of HDAC11 in obesity-related metabolic disorders: A critical review

J Cell Physiol. 2021 Aug;236(8):5582-5591. doi: 10.1002/jcp.30286. Epub 2021 Jan 22.

Abstract

At present, metabolic diseases, such as obesity and diabetes, have become the world's top health threats. These diseases are closely related to the abnormal development and function of adipocytes and metabolic inflammation associated with obesity. Histone deacetylase 11 (HDAC11), with a relatively unique structure and function in the HDAC family, plays a vital role in regulating cell growth, migration, and cell death. Currently, research on new key regulatory functions of HDAC11 in metabolic homeostasis is receiving more and more attention, and HDAC11 has also become a potential therapeutic target in the treatment of obesity and obesity-related diseases. Here, we summarized the latest literature on the role of HDAC11 in regulating the progress of obesity-related metabolic disorders.

Keywords: HDAC11; metabolic inflammation; obesity.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cell Proliferation / drug effects
  • Histone Deacetylase Inhibitors / therapeutic use*
  • Histone Deacetylases / drug effects
  • Histone Deacetylases / metabolism*
  • Humans
  • Inflammation / drug therapy
  • Obesity / drug therapy*

Substances

  • Histone Deacetylase Inhibitors
  • HDAC11 protein, human
  • Histone Deacetylases